Clinical Trials Directory

Trials / Sponsors / Shanghai Shengdi Pharmaceutical Co., Ltd

Shanghai Shengdi Pharmaceutical Co., Ltd

Industry · 9 registered clinical trials — 6 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingClinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Jun
Locally Advanced Gastric or Gastroesophageal Junction Cancer
Phase 32026-05-01
RecruitingA Study of SHR-4610 Injection in Patients With Advanced Solid Tumors
Solid Tumors
Phase 1 / Phase 22025-11-20
RecruitingA Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for
For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions
Phase 32025-11-17
RecruitingA Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for
For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Abnormal Vascular Lesions in Body Regions Excluding the Central Nervous System (CNS)
Phase 32025-11-14
RecruitingA Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined W
Advanced Cervical Cancer
Phase 32025-10-17
CompletedPharmacokinetics, Dialysability and Safety of HRS-9231 in Healthy Volunteers and in Patients With Impaired Ren
Contrast-Enhanced Magnetic Resonance Imaging Detection
Phase 12024-10-14
CompletedPharmacokinetics, Pharmacodynamics Profile and Tolerance of HRS-9231 in Healthy Subjects
Healthy Volunteers
Phase 12024-06-05
Active Not RecruitingA Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer
Locally Advanced Cervical Cancer
Phase 22024-03-20
Not Yet RecruitingA Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NS
Non-squamous Non-small Cell Lung Cancer
Phase 2 / Phase 32024-03-01